Index

• Pages: 371-391
• Author: Davis M. Walsh,Samuel L. Tarry

A

absent plaintiffs, 285

acronyms commonly used in

medical records, 217

actions in MDL, 268

acute idiopathic pulmonary

hemorrhage (AIPH), 37

ADA. See Americans with

Disabilities Act (ADA)

adequacy of representation, in Rule

23(a), 289–290

AIDS

epidemic, 5, 31–32, 33

insurance coverage, 193

airborne pathogens, 3

all-purpose jurisdiction, 236–239

American Law Institute, 52, 163

American National Standards

Institute (ANSI), 86–87

American Society for Microbiology, 7

Americans with Disabilities Act

(ADA), 122, 138–142

COVID-19 protocols, 138–140

disability discrimination,

140–142

employment disability

lawsuits, 138

failure to accommodate, 142

analogy, in Hill’s nine criteria, 43

analytic epidemiology, 28–29

analytical microbiology methods in

epidemiological

investigations, 15–18

classical culture-based

biochemical techniques,

15–16

MALDI-TOF MS, 5, 17

PFGE, 5, 16–17

plasmid-based analyses, 16

plasmid typing, 5, 16

stereotyping, 16

WGS, 5, 17–18

animal magnetism, 24

animals

antimicrobial resistance in, 11

ferae naturae defense and, 90

microorganisms in, 2, 6, 7

ANSI (American National

Standards Institute), 86–87

antibiotics

development of, 4–5

microbial survival/growth

and, 9

resistance to, 11–12

antimicrobial resistance, 11–12

aquatic environments,

microorganisms in, 2, 6

archaea, 1, 6

Index

371

Tarry_IDX.indd 371 27/01/21 4:24 PM

ascertainability, in Rule 23(a),

290–291

awards of punitive damages

amount of, statutory and

constitutional limitations on,

319–321

application of, 309–319

concealing an outbreak,

313–314

harm, trying to mitigate,

315–317

ignoring an outbreak, 314–315

prior incidents or warnings,

310–312

reprehensible conduct, 317–319

B

Bacillus tetani, 8

bacteria

antibiotic-resistant, 11–12

in classication of

microorganisms, 6

in discovery planning, 200

in epidemiological investigations,

15–18

in history of microbiology, 4–5

in microbial world, 1

insurance coverage

civil authority coverage, 184

exclusions, 191–192

products liability and, 51, 76

survival, growth, and transport

of, 9–11

waterborne, 14

bacterial diseases

acronyms for commonly used, in

medical records, 217

food outbreaks, 96, 99–100, 105

in medical chronology, 221

negligence and, 83, 84

NIED claim and, 89

outbreaks

class actions and, 301–302

reprehensible conduct and,

317–319

pneumonias, 14

premises liability and, 79, 83, 84,

86–87

protocols for preventing

outbreaks, 91

transmission of, 3, 11

travel-related infection compared

to, 84

treatments for, development

of, 4

bacterial subtyping, 16

bellwether trials, 282–283, 328

bias, 34–38

bifurcation, 322–323

bioinformatics, 5

biological gradient, in Hill’s nine

criteria, 42

biotechnology applications, 2

bodily injury exclusion, 188

burden of proof, in establishing

personal jurisdiction,

258–259

business associate, 225, 227–228

Business Associates

Agreement, 228

business closings. See mass layoffs

and business closings

Business Interruption insurance,

180–181, 193–197

business operations during

outbreaks, limits on,

152–153

C

CAFA. See Class Action

Fairness Act

case-control studies, 29

case-linked jurisdiction, 236–239

case management in MDL,

initial, 274

committees of counsel, 274

lead counsel, 274

liaison counsel, 274

cases at jury trials, consolidation of,

326–328

372 Infectious Disease Litigation

Tarry_IDX.indd 372 27/01/21 4:24 PM